Primary outcome ‐ constipation improvement · women with treating constipation in pregnancy
Stimulant laxatives probably leads to higher primary outcome ‐ constipation improvement compared with bulk‐forming laxatives (moderate certainty).
1 finding from 1 review
Primary outcome ‐ pain on defecation ‐ not reported · women with treating constipation in pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of defecation (mean number of bowel movements per week) · women with treating constipation in pregnancy
1 finding from 1 review
Stool consistency · women with treating constipation in pregnancy
1 finding from 1 review
Secondary outcome ‐ abdominal discomfort · women with treating constipation in pregnancy
Stimulant laxatives probably leads to higher secondary outcome ‐ abdominal discomfort compared with bulk‐forming laxatives (moderate certainty).
1 finding from 1 review
Diarrhoea · women with treating constipation in pregnancy
Stimulant laxatives may leads to higher secondary outcome ‐ diarrhoea compared with bulk‐forming laxatives (low certainty).
1 finding from 1 review
Secondary outcome ‐ women's satisfaction · women with treating constipation in pregnancy
Stimulant laxatives showed no clear difference in secondary outcome ‐ women's satisfaction compared with bulk‐forming laxatives (moderate certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
S uccessful disimpaction · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG showed no clear difference in S uccessful disimpaction compared with enema (low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Need for extra treatment · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether PEG changes need for additional therapies compared with flixweed (very low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Need for extra treatment · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether PEG changes need for additional therapies compared with dietary fibre (very low certainty).
1 finding from 1 review
Frequency of faecal incontinence · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · patients aged 0 to 18 years with a diagnosis of functional constipation
1 finding from 1 review
Need for extra treatment · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether high dose PEG changes need for additional therapy compared with low dose PEG (very low certainty).
1 finding from 1 review
Serious adverse events · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Faecal incontinence · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether high dose PEG changes faecal incontinence compared with low dose PEG (very low certainty).
1 finding from 1 review